Circ-Tulp4 promotes β-cell adaptation to lipotoxicity by regulating soat1 expression

Liting Wu1, Li Xiong1, Jin Li1,2

  • 1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Insights

Circular RNA circ-Tulp4 is downregulated in type 2 diabetes (T2DM) and regulates beta-cell proliferation. It impacts the miR-7222-3p/SOAT1/cyclin D1 pathway, suggesting circ-Tulp4 as a potential T2DM therapeutic target.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Type 2 diabetes (T2DM) is characterized by beta-cell dysfunction.
  • Circular RNAs (circRNAs) are implicated in various diseases, but their role in T2DM beta-cells is not fully understood.

Purpose of the Study:

  • To identify differentially expressed circRNAs in T2DM models.
  • To investigate the function of circ-Tulp4 in regulating beta-cell function and its underlying molecular mechanisms.

Main Methods:

  • High-throughput RNA sequencing to identify dysregulated circRNAs in diabetic mouse islets.
  • Real-time PCR to validate circ-Tulp4 expression.
  • Cell proliferation assays (MTS, EdU), Western blot, and flow cytometry to assess beta-cell function.
  • Luciferase assay to confirm molecular interactions.

Main Results:

  • Thousands of circRNAs were identified in mouse pancreatic islets; circ-Tulp4 expression was significantly decreased in diabetic models and under lipotoxic conditions in Min6 cells.
  • Modulation of circ-Tulp4 affected Min6 cell proliferation.
  • Circ-Tulp4 interacts with miR-7222-3p to suppress SOAT1 expression, leading to SOAT1 accumulation and subsequent activation of cyclin D1, promoting cell cycle progression.

Conclusions:

  • Circ-Tulp4 regulates beta-cell proliferation through the miR-7222-3p/SOAT1/cyclin D1 signaling pathway.
  • Circ-Tulp4 represents a potential therapeutic target for T2DM.
  • SOAT1 may play a crucial role in beta-cell adaptation to lipotoxicity.